Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 10 | 2025 | 492 | 1.140 |
Why?
|
| Child | 34 | 2026 | 4656 | 0.740 |
Why?
|
| Surgeons | 5 | 2025 | 191 | 0.740 |
Why?
|
| Child, Preschool | 22 | 2026 | 2090 | 0.670 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2011 | 14 | 0.670 |
Why?
|
| Braces | 2 | 2014 | 10 | 0.650 |
Why?
|
| Hospitals | 2 | 2023 | 399 | 0.610 |
Why?
|
| Intestinal Obstruction | 3 | 2012 | 54 | 0.580 |
Why?
|
| Specialties, Surgical | 3 | 2025 | 46 | 0.560 |
Why?
|
| Urinary Tract Infections | 2 | 2011 | 97 | 0.540 |
Why?
|
| Appendicitis | 3 | 2018 | 84 | 0.520 |
Why?
|
| Infant | 17 | 2026 | 1721 | 0.470 |
Why?
|
| Orchiopexy | 2 | 2026 | 12 | 0.470 |
Why?
|
| Cryptorchidism | 2 | 2026 | 20 | 0.470 |
Why?
|
| Adolescent | 24 | 2026 | 6372 | 0.430 |
Why?
|
| Postoperative Complications | 6 | 2026 | 1336 | 0.430 |
Why?
|
| Time-to-Treatment | 2 | 2026 | 133 | 0.430 |
Why?
|
| Retrospective Studies | 21 | 2026 | 6961 | 0.420 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.410 |
Why?
|
| Humans | 59 | 2026 | 65883 | 0.370 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 22 | 0.370 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 33 | 0.350 |
Why?
|
| Treatment Outcome | 15 | 2025 | 5836 | 0.350 |
Why?
|
| Bites and Stings | 1 | 2011 | 10 | 0.350 |
Why?
|
| Male | 36 | 2026 | 31446 | 0.340 |
Why?
|
| Facial Injuries | 1 | 2011 | 13 | 0.340 |
Why?
|
| Cicatrix | 2 | 2011 | 62 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 312 | 0.340 |
Why?
|
| Wound Infection | 1 | 2011 | 29 | 0.340 |
Why?
|
| Dextrans | 2 | 2009 | 46 | 0.330 |
Why?
|
| Colectomy | 1 | 2012 | 123 | 0.330 |
Why?
|
| Pediatrics | 2 | 2025 | 265 | 0.330 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 71 | 0.320 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 70 | 0.320 |
Why?
|
| Dogs | 1 | 2011 | 326 | 0.310 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2015 | 116 | 0.300 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 42 | 0.300 |
Why?
|
| Female | 32 | 2026 | 34470 | 0.290 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 72 | 0.290 |
Why?
|
| Infant, Newborn | 13 | 2025 | 1441 | 0.270 |
Why?
|
| Fundoplication | 2 | 2025 | 26 | 0.270 |
Why?
|
| Thoracoscopy | 3 | 2004 | 29 | 0.260 |
Why?
|
| Laparoscopes | 1 | 2007 | 23 | 0.260 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.260 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 6 | 0.260 |
Why?
|
| Choristoma | 1 | 2007 | 23 | 0.250 |
Why?
|
| Intussusception | 1 | 2007 | 16 | 0.250 |
Why?
|
| Stomach | 1 | 2007 | 87 | 0.250 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 130 | 0.250 |
Why?
|
| Spleen | 2 | 2012 | 476 | 0.240 |
Why?
|
| Mediastinal Emphysema | 1 | 2026 | 12 | 0.240 |
Why?
|
| Sternum | 1 | 2006 | 29 | 0.240 |
Why?
|
| Legislation, Drug | 1 | 2026 | 22 | 0.240 |
Why?
|
| Sutures | 2 | 2016 | 40 | 0.230 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 154 | 0.230 |
Why?
|
| Thoracic Wall | 1 | 2006 | 23 | 0.230 |
Why?
|
| Catheterization, Central Venous | 2 | 1997 | 84 | 0.230 |
Why?
|
| Anus, Imperforate | 1 | 2005 | 3 | 0.230 |
Why?
|
| Residence Characteristics | 2 | 2026 | 230 | 0.230 |
Why?
|
| Metals, Rare Earth | 1 | 2025 | 7 | 0.230 |
Why?
|
| Magnets | 1 | 2025 | 9 | 0.230 |
Why?
|
| Urethral Diseases | 1 | 2005 | 13 | 0.230 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 50 | 0.230 |
Why?
|
| Urinary Fistula | 1 | 2005 | 17 | 0.230 |
Why?
|
| Colonic Diseases | 1 | 2005 | 35 | 0.220 |
Why?
|
| Rectal Fistula | 1 | 2005 | 21 | 0.220 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 17 | 0.220 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 93 | 0.220 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.220 |
Why?
|
| Peritonitis | 1 | 2025 | 43 | 0.220 |
Why?
|
| Occupational Stress | 1 | 2025 | 22 | 0.220 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 47 | 0.220 |
Why?
|
| Urethra | 1 | 2005 | 77 | 0.220 |
Why?
|
| Foreign Bodies | 1 | 2025 | 56 | 0.220 |
Why?
|
| Occupational Injuries | 1 | 2025 | 38 | 0.210 |
Why?
|
| Ergonomics | 1 | 2025 | 79 | 0.210 |
Why?
|
| Continuity of Patient Care | 1 | 2025 | 175 | 0.200 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 2500 | 0.200 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 1663 | 0.190 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 27 | 0.180 |
Why?
|
| Musa | 1 | 2021 | 6 | 0.180 |
Why?
|
| Hypocalcemia | 1 | 2022 | 19 | 0.180 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.180 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 8 | 0.170 |
Why?
|
| Stomach Volvulus | 1 | 2001 | 5 | 0.170 |
Why?
|
| Splenic Diseases | 1 | 2001 | 14 | 0.170 |
Why?
|
| Intestinal Atresia | 1 | 2001 | 3 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2025 | 449 | 0.170 |
Why?
|
| Duodenal Obstruction | 1 | 2001 | 5 | 0.170 |
Why?
|
| Common Bile Duct | 1 | 2001 | 21 | 0.170 |
Why?
|
| Length of Stay | 4 | 2015 | 829 | 0.170 |
Why?
|
| Esophageal Atresia | 2 | 2004 | 9 | 0.170 |
Why?
|
| Boston | 1 | 2022 | 259 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2020 | 40 | 0.160 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 122 | 0.150 |
Why?
|
| Pediatricians | 1 | 2020 | 63 | 0.150 |
Why?
|
| Lung | 1 | 2004 | 970 | 0.140 |
Why?
|
| Appendix | 1 | 2018 | 17 | 0.140 |
Why?
|
| Incidence | 4 | 2026 | 1434 | 0.140 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2013 | 881 | 0.140 |
Why?
|
| Phytotherapy | 1 | 2018 | 34 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2018 | 54 | 0.130 |
Why?
|
| Fibroblasts | 2 | 1997 | 423 | 0.130 |
Why?
|
| Hypertension, Renal | 1 | 1997 | 5 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 131 | 0.130 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1997 | 7 | 0.130 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 16 | 0.130 |
Why?
|
| Parenteral Nutrition | 1 | 1997 | 20 | 0.130 |
Why?
|
| Pharynx | 1 | 1997 | 25 | 0.120 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 23 | 0.120 |
Why?
|
| Hematoma | 1 | 1997 | 85 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2018 | 130 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 88 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 532 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 491 | 0.120 |
Why?
|
| Esophagostomy | 1 | 1996 | 1 | 0.120 |
Why?
|
| Blood Proteins | 1 | 1996 | 84 | 0.120 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1996 | 20 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2742 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 413 | 0.110 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 67 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 1996 | 53 | 0.110 |
Why?
|
| Postoperative Care | 1 | 1996 | 126 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 148 | 0.110 |
Why?
|
| Pancreas | 1 | 2015 | 153 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 993 | 0.110 |
Why?
|
| Kidney | 1 | 1997 | 460 | 0.110 |
Why?
|
| Age Factors | 3 | 2013 | 1595 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2013 | 757 | 0.100 |
Why?
|
| Drainage | 2 | 2011 | 153 | 0.100 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 645 | 0.090 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 48 | 0.090 |
Why?
|
| Soft Tissue Infections | 2 | 2011 | 48 | 0.090 |
Why?
|
| Community-Acquired Infections | 2 | 2011 | 95 | 0.090 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 4 | 0.090 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.090 |
Why?
|
| Firearms | 1 | 2013 | 63 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 50 | 0.090 |
Why?
|
| United States | 6 | 2025 | 8192 | 0.090 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 33 | 0.090 |
Why?
|
| Neutropenia | 1 | 2012 | 68 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 237 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1572 | 0.090 |
Why?
|
| Rectum | 2 | 2005 | 97 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 57 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 20 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2014 | 370 | 0.080 |
Why?
|
| Equipment Design | 2 | 2007 | 374 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 59 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.080 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 50 | 0.080 |
Why?
|
| Ureteroscopy | 1 | 2011 | 19 | 0.080 |
Why?
|
| Operating Rooms | 1 | 2011 | 60 | 0.080 |
Why?
|
| Esophagus | 2 | 2004 | 47 | 0.080 |
Why?
|
| Emergencies | 1 | 2011 | 124 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2011 | 97 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 66 | 0.080 |
Why?
|
| Acute Disease | 1 | 2012 | 665 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2791 | 0.080 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 12 | 0.080 |
Why?
|
| Surgical Stapling | 1 | 2010 | 11 | 0.080 |
Why?
|
| Gastroscopy | 1 | 2010 | 23 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 30 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 193 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1720 | 0.070 |
Why?
|
| Splenectomy | 2 | 2012 | 39 | 0.070 |
Why?
|
| Bacteriuria | 1 | 2007 | 16 | 0.060 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 90 | 0.060 |
Why?
|
| Funnel Chest | 1 | 2005 | 7 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2005 | 29 | 0.060 |
Why?
|
| Wound Healing | 2 | 2016 | 193 | 0.060 |
Why?
|
| Gynecomastia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Prostatic Diseases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2005 | 48 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2005 | 14 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2005 | 20 | 0.060 |
Why?
|
| Colostomy | 1 | 2005 | 25 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 23 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 22 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 85 | 0.060 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 665 | 0.060 |
Why?
|
| Adult | 7 | 2025 | 17601 | 0.060 |
Why?
|
| Cannabis | 1 | 2026 | 54 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2005 | 50 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 29 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2007 | 3341 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 809 | 0.050 |
Why?
|
| Operative Time | 1 | 2025 | 94 | 0.050 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.050 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.050 |
Why?
|
| Reoperation | 1 | 2025 | 307 | 0.050 |
Why?
|
| Pressure | 1 | 2004 | 80 | 0.050 |
Why?
|
| Animals | 4 | 2016 | 21498 | 0.050 |
Why?
|
| Hand Injuries | 1 | 2003 | 14 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 243 | 0.050 |
Why?
|
| Massachusetts | 2 | 2026 | 2161 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 398 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 46 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 84 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 26 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 932 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 37 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 464 | 0.050 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 10 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2022 | 4 | 0.040 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 10 | 0.040 |
Why?
|
| Pylorus | 1 | 2021 | 8 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2022 | 35 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2002 | 98 | 0.040 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2001 | 21 | 0.040 |
Why?
|
| Mouth Diseases | 1 | 2001 | 15 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2025 | 523 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2022 | 83 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 2001 | 38 | 0.040 |
Why?
|
| Cisplatin | 1 | 2002 | 145 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 33 | 0.040 |
Why?
|
| Cysts | 1 | 2001 | 44 | 0.040 |
Why?
|
| Laparotomy | 1 | 2001 | 56 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 1274 | 0.040 |
Why?
|
| Urogenital System | 1 | 2001 | 3 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2015 | 889 | 0.040 |
Why?
|
| Cesarean Section | 2 | 2001 | 105 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2013 | 2116 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 1231 | 0.040 |
Why?
|
| Fetus | 2 | 2001 | 103 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 559 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 309 | 0.040 |
Why?
|
| Birth Injuries | 1 | 1998 | 2 | 0.040 |
Why?
|
| Rectovaginal Fistula | 1 | 1998 | 3 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 7 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 9 | 0.030 |
Why?
|
| Cytotoxins | 1 | 2018 | 11 | 0.030 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 32 | 0.030 |
Why?
|
| Rhodiola | 1 | 2018 | 15 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 1998 | 29 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 53 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 466 | 0.030 |
Why?
|
| Vagina | 1 | 1998 | 87 | 0.030 |
Why?
|
| Communication | 1 | 2023 | 608 | 0.030 |
Why?
|
| Femoral Vein | 1 | 1997 | 20 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 437 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 86 | 0.030 |
Why?
|
| Collagen | 1 | 1997 | 135 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 200 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 1997 | 35 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2010 | 128 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 588 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1996 | 1 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 13 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 712 | 0.030 |
Why?
|
| Exercise | 1 | 2003 | 970 | 0.030 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1996 | 5 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1996 | 28 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1996 | 29 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 202 | 0.030 |
Why?
|
| Gestational Age | 1 | 1996 | 198 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2653 | 0.030 |
Why?
|
| Ischemia | 1 | 1997 | 203 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 253 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2328 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1044 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1573 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 663 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1030 | 0.020 |
Why?
|
| Urban Population | 1 | 2013 | 201 | 0.020 |
Why?
|
| Cell Line | 1 | 1996 | 2031 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 579 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 4887 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 307 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 2324 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 252 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 262 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 806 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 995 | 0.020 |
Why?
|
| Clavulanic Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Ticarcillin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 13 | 0.020 |
Why?
|
| Penicillins | 1 | 1989 | 32 | 0.020 |
Why?
|
| Gentamicins | 1 | 1989 | 24 | 0.020 |
Why?
|
| Retreatment | 1 | 2009 | 43 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 18526 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1989 | 151 | 0.020 |
Why?
|
| Mastectomy, Simple | 1 | 2005 | 2 | 0.010 |
Why?
|
| Tidal Volume | 1 | 2005 | 41 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 134 | 0.010 |
Why?
|
| Sus scrofa | 1 | 2004 | 30 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 257 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 183 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 118 | 0.010 |
Why?
|
| Accidents, Home | 1 | 2003 | 9 | 0.010 |
Why?
|
| Contracture | 1 | 2003 | 9 | 0.010 |
Why?
|
| Finger Injuries | 1 | 2003 | 16 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 154 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 116 | 0.010 |
Why?
|
| Pregnancy | 2 | 2001 | 2411 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 15161 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 593 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2001 | 7 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2001 | 47 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 50 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 117 | 0.010 |
Why?
|
| Circumcision, Male | 1 | 2001 | 8 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 73 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2002 | 199 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1998 | 1 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1998 | 245 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 162 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 38 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1998 | 184 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 491 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 182 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1997 | 377 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 515 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1998 | 556 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5478 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 1236 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 2194 | 0.010 |
Why?
|
| Abdomen | 1 | 1989 | 97 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 462 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 811 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 5685 | 0.000 |
Why?
|